Log in to save to my catalogue

A Phase III Randomized Placebo-Controlled Trial to Evaluate Efficacy and Safety of Romosozumab in Me...

A Phase III Randomized Placebo-Controlled Trial to Evaluate Efficacy and Safety of Romosozumab in Me...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2058499473

A Phase III Randomized Placebo-Controlled Trial to Evaluate Efficacy and Safety of Romosozumab in Men With Osteoporosis

About this item

Full title

A Phase III Randomized Placebo-Controlled Trial to Evaluate Efficacy and Safety of Romosozumab in Men With Osteoporosis

Publisher

United States: Copyright Oxford University Press

Journal title

The journal of clinical endocrinology and metabolism, 2018-09, Vol.103 (9), p.3183-3193

Language

English

Formats

Publication information

Publisher

United States: Copyright Oxford University Press

More information

Scope and Contents

Contents

Globally, one in five men aged >50 years is predicted to experience an osteoporotic fracture. Because of the treatment gap in osteoporosis and the paucity of bone-forming agents for men, new osteoporosis treatments are needed.
To evaluate the safety and efficacy of romosozumab in men with osteoporosis.
Phase III randomized BRIDGE study (place...

Alternative Titles

Full title

A Phase III Randomized Placebo-Controlled Trial to Evaluate Efficacy and Safety of Romosozumab in Men With Osteoporosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2058499473

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2058499473

Other Identifiers

ISSN

0021-972X

E-ISSN

1945-7197

DOI

10.1210/jc.2017-02163

How to access this item